1261398-53-1
1261398-53-1
Chemical Structure
Mephenytoin-13C,d3
- CAS No.: 1261398-53-1
- Formula:C1113CH11D3N2O2
- Molecular Weight:222.26
InChIKey: GMHKMTDVRCWUDX-JVXUGDAPSA-N
SMILES: CCC1(C2=CC=CC=C2)C(N(C(N1)=O)[13C]([2H])([2H])[2H])=O
Biological Activity: Mephenytoin-13C,d3 is a deuterated labeled Mephenytoin[1]. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Mephenytoin-13C,d3 | Mephenytoin-13C,d3 is a deuterated labeled Mephenytoin. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mephenytoin (Standard) | ≥98% | Mephenytoin (Standard) is the analytical standard of Mephenytoin. This product is intended for research and analytical applications. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mephenytoin-d8 | Mephenytoin-d8 is the deuterium labeled Mephenytoin. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mephenytoin-d5 | 98.72% | Mephenytoin-d5 is the deuterium labeled Mephenytoin. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mephenytoin-d3 | 99.52% | (Rac)-Mephenytoin-d3 is a labelled racemic Mephenytoin. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mephenytoin | 99.96% | Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. D R Minck, et al. Comparison of the behavioral teratogenic potential of phenytoin, mephenytoin, ethotoin, and hydantoin in rats. Teratology. 1991 Apr;43(4):279-93. [Content Brief]
